All influenza articles
-
NewsTrials show common cold medication significantly improved symptoms in less than two days
Applied Biological Laboratories will present results of a clinical trial which showed Biovanta significantly improved common cold symptoms including sore throat, cough, runny nose, congestion, chills, and sneezing in less than two days.
-
NewsResearchers confront new US and global challenges in vaccinations of adults
Decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.
-
NewsChild Health Day 2024: influenza vaccine protects children from infection and hospitalization
Spain’s influenza vaccination campaign for children aged 6-59 months during the 2023/24 season was effective in preventing acute respiratory infections and hospitalisation, as vaccination was recommended for this age group at the national level for the first time.
-
NewsBovine H5N1 influenza may spread via milking
Milking practices may be linked to the transmission of bovine H5N1 influenza virus, which affects dairy cattle and was first detected in the U.S. in spring 2024.
-
NewsVaccinating the young can save the old in the Tropics
A model suggests that vaccinating children and teens against the flu can help protect the elderly in tropical countries.
-
NewsGetting the flu and then your shot may benefit immunity
In a new study, researchers have found that natural immunity from previous flu infections has a significant impact on how well future influenza vaccinations work.
-
News$12 million grant to research how vaccines induce lasting immunity
Researchers have received a $12 million grant to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.
-
NewsEradivir closes $10.25M Series A funding round for next stage of influenza therapeutic trials
Eradivir, a preclinical biotech company that develops antiviral therapeutics, has completed a $10.25 million Series A funding round which will be used to conduct a Phase 2a challenge study of its EV25 influenza treatment.
-
NewsIncreased ventilation not effective in reducing influenza virus spread in play-based model
Increasing ventilation in child-care settings may not always be effective at preventing flu virus spread, according to a new study.
-
NewsInfluenza viruses can use two ways to infect cells, study finds
Scientists have discovered that certain human flu viruses and avian flu viruses can use a second entry pathway, a protein complex of the immune system, to infect cells, helping the viruses to infect different species.
-
NewsFrom ‘hit to vial’: Discovery and optimization of a promising vaccine adjuvant
Scientists identified a new and promising adjuvant, dubbed PVP-037 - in principle, this compound can be added to any vaccine to enhance its action.
-
NewsNew electrostatic sampler boosts indoor virus detection speed
Researchers have developed a groundbreaking electrostatic air sampler that enhances the rapid monitoring of airborne influenza and coronavirus.
-
![Low-Res_Compound 7 with influenza H1 hemagglutinin_Credit Seiya Kitamura[1]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/4/1/4/7414_lowres_compound7withinfluenzah1hemagglutinin_creditseiyakitamura1_295508_crop.jpg)
NewsDrug-like inhibitor shows promise in preventing flu
Scientists have developed a potential drug-like molecule that blocks the first stage of type A influenza infection.
-
NewsMore than half of global infectious diseases experts surveyed rate influenza as the number one pathogen of concern of pandemic potential
When infectious diseases experts were asked to rank pathogens in order of their pandemic potential, influenza was considered the pathogen of highest pandemic risk, with 57% ranking it as number one, and 17% ranking it second.
-
NewsNew antibodies target “dark side” of influenza virus protein
Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.
-
NewsInteractions between flu subtypes predict epidemic severity more than virus evolution
An analysis of influenza virus evolution over 22 years of flu seasons reveals the major drivers of disease transmission and epidemic severity.
-
NewsSevere lung damage caused when flu is followed by infection with measles-like virus
Infection with a measles-like virus causes catastrophic lung failure in ferrets previously infected with influenza virus or respiratory syncytial virus, according to a new study.
-
NewsGut microbiota influence severity of respiratory viral infection
The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, a new study reveals.
-
NewsStudy sheds light on how viral infections interact with our bodies
A new longitudinal study of symptomatic, asymptomatic, and mild infections sheds light on how our bodies respond to these infections on a molecular level.
-
NewsVaccine speeds up the production of antibodies against Covid
A new vaccine uses preexisting immunity to a separate virus (the influenza virus) to help kickstart the process of making antibodies against SARS-CoV-2.
